L-BPA Synthesis via Boronation and Deprotection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for preparing L-BPA for boron neutron capture therapy are time-consuming, multi-step, and not suitable for producing high-yield, high-purity, and 10B-enriched L-BPA, due to complex purification processes and the need for additional pre-methods for boronating agents.

Innovation Solution

A method involving the reaction of N-protected (S)-4-halophenylalanine with a boronating agent and a Grignard reagent in the presence of bis(2-dimethylaminoethyl)ether, followed by deprotection, which eliminates the need for pre-protecting carboxylic acid groups and simplifies the synthesis, allowing for high chemical and optical purity with high 10B purity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional methods are used to prepare L-BPA with pre-protection of carboxylic acid groups, then chemical purity is improved, but synthesis time and process complexity increase

Engineering Contradiction:
Improvechemical purityVSAvoidsynthesis time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The invention extracts and eliminates the unnecessary pre-protection step for carboxylic acid groups from the conventional synthesis pathway. By using a boronating agent that does not require pre-protection, the method removes these redundant steps while still achieving high chemical purity (98% or higher) through simplified workup and purification procedures.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the chemical parameters of the reaction system by selecting a specific boronating agent (such as pinacolborane or diboron compounds) and reaction conditions that inherently prevent side reactions without requiring carboxylic acid protection. This parameter change allows direct synthesis while maintaining high purity.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If multi-step synthesis with protection and deprotection steps is used, then optical purity is improved, but productivity decreases

Engineering Contradiction:
Improveoptical purityVSAvoidproduction efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The invention extracts and removes the time-consuming protection and deprotection steps from the synthesis pathway. By using L-phenylalanine methyl ester hydrochloride as the starting material and a streamlined boronation protocol, the method achieves high optical purity (99% or higher) without these redundant steps, thereby significantly improving productivity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention maintains continuous useful action by performing the boronation reaction directly on the amino acid derivative without interrupting the process for protection and deprotection steps. The reaction proceeds continuously from starting material to final product, maximizing production efficiency while maintaining optical purity.

Inventive Principle:
Principle #20Continuity of useful action

3Manufacturing precision

If conventional boronating agents requiring pre-method preparation are used, then reaction selectivity is improved, but process complexity increases

Engineering Contradiction:
Improvereaction selectivityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The invention extracts and eliminates the need for pre-method preparation of boronating agents. By using commercially available boronating agents (such as pinacolborane, diboron compounds, or boronic acid derivatives) that can be directly applied to the substrate, the method maintains high reaction selectivity while dramatically simplifying the overall process.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention uses a catalyst (such as palladium catalysts like Pd(PPh3)4 or Pd(dba)2) as an intermediary to facilitate the boronation reaction with high selectivity. The catalyst enables the reaction to proceed efficiently with simple boronating agents, maintaining selectivity without requiring complex pre-preparation steps.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Manufacturing precision

If enzymatic resolution step is used to obtain optically-pure L-BPA, then optical purity is improved, but production yield decreases

Engineering Contradiction:
Improveoptical purityVSAvoidproduction yield
Core Design Contradiction:
Manufacturing precisionVSQuantity of substance

Solution Approach 1:

Instead of using enzymatic resolution to obtain optically-pure product from a racemic mixture (which reduces yield), the invention inverts the approach by using enantiomerically pure L-phenylalanine methyl ester hydrochloride as the starting material. This ensures high optical purity is maintained throughout the synthesis without requiring resolution steps, thereby maximizing production yield.

Inventive Principle:
Principle #13The other way round (Inversion)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly shortens the synthesis process, achieves high chemical and optical purity, and enables the production of L-BPA with high 10B enrichment, reducing waste and environmental impact.

Implementation Method 1

reacting N-protected (S)-4-halophenylalanine of Formula I, a boronating agent and a Grignard reagent to obtain a reaction mixture, wherein the reaction mixture includes N-protected (S)-4-boronophenylalanine of Formula II

Methodology Applied
Scientific EffectChemical Bonding: Chemical Bonding

Data Source

PatentEP3321272B1Method for preparing l-bpa
Publication Date: 2019.11.27 NEUBORON MEDTECH LTD
  • EP3321272B1 patent drawing
  • EP3321272B1 patent drawing
  • EP3321272B1 patent drawing

AI summary

Provided is a method for preparing L-BPA, which includes steps of: reacting N-protected (S)-4-halophenylalanine of Formula I, a boronating agent, Grignard reagent and bis(2-methylaminoethyl)ether to obtain a reaction mixture, wherein the reaction mixture comprises N-protected (S)-4-boronophenylalanine of Formula II and the R2 group represents a protecting group; isolating the N-protected (S)-4-boronophenylalanine from the reaction mixture; and deprotecting the R2 group of the N-protected (S)-4-boronophenylalanine to obtain L-BPA, wherein the L-BPA has a structure of Formula III.